167 related articles for article (PubMed ID: 22024968)
1. Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines.
Müller AC; Kanfer I
Biopharm Drug Dispos; 2011 Nov; 32(8):458-70. PubMed ID: 22024968
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cytotoxic, genotoxic and CYP450 enzymatic competition effects of Tanzanian plant extracts traditionally used for treatment of fungal infections.
van den Bout-van den Beukel CJ; Hamza OJ; Moshi MJ; Matee MI; Mikx F; Burger DM; Koopmans PP; Verweij PE; Schoonen WG; van der Ven AJ
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):515-26. PubMed ID: 18331392
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
5. Warfarin-antiretroviral interactions.
Liedtke MD; Rathbun RC
Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
[TBL] [Abstract][Full Text] [Related]
6. Impact of traditional medicinal plant extracts on antiretroviral drug absorption.
Brown L; Heyneke O; Brown D; van Wyk JP; Hamman JH
J Ethnopharmacol; 2008 Oct; 119(3):588-92. PubMed ID: 18640255
[TBL] [Abstract][Full Text] [Related]
7. St. John's wort warning: do not combine with protease inhibitors, NNRTIs.
James JS
AIDS Treat News; 2000 Feb; (No 337):3-5. PubMed ID: 11367207
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of human cytochrome P450 and P-glycoprotein-mediated metabolism of some phytochemicals in extracts and formulations of African potato.
Nair VD; Foster BC; Thor Arnason J; Mills EJ; Kanfer I
Phytomedicine; 2007 Aug; 14(7-8):498-507. PubMed ID: 17336049
[TBL] [Abstract][Full Text] [Related]
9. Interactions of herbs with cytochrome P450.
Zhou S; Gao Y; Jiang W; Huang M; Xu A; Paxton JW
Drug Metab Rev; 2003 Feb; 35(1):35-98. PubMed ID: 12635815
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
Fabbiani M; Di Giambenedetto S; Bracciale L; Bacarelli A; Ragazzoni E; Cauda R; Navarra P; De Luca A
J Antimicrob Chemother; 2009 Jul; 64(1):109-17. PubMed ID: 19398461
[TBL] [Abstract][Full Text] [Related]
11. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
Joly V; Descamps D; Yeni P
AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
[TBL] [Abstract][Full Text] [Related]
12. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
13. Potential for interaction of kava and St. John's wort with drugs.
Singh YN
J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
[TBL] [Abstract][Full Text] [Related]
14. The role of cytochrome P450 in antiretroviral drug interactions.
Walubo A
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):583-98. PubMed ID: 17696808
[TBL] [Abstract][Full Text] [Related]
15. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
16. Identification of Mechanism and Pathway of the Interaction between the African Traditional Medicine, Sutherlandia Frutescens, and the Antiretroviral Protease Inhibitor, Atazanavir, in Human Subjects Using Population Pharmacokinetic (PK) Analysis.
Muller AC; Ducharme MP; Kanfer I
J Pharm Pharm Sci; 2018; 21(1s):215s-221s. PubMed ID: 30158052
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate?
Butterweck V; Derendorf H; Gaus W; Nahrstedt A; Schulz V; Unger M
Planta Med; 2004 Sep; 70(9):784-91. PubMed ID: 15386186
[TBL] [Abstract][Full Text] [Related]
18. Interactions between recreational drugs and antiretroviral agents.
Antoniou T; Tseng AL
Ann Pharmacother; 2002 Oct; 36(10):1598-613. PubMed ID: 12243611
[TBL] [Abstract][Full Text] [Related]
19. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
[TBL] [Abstract][Full Text] [Related]
20. Impact of traditional African medicine on drug metabolism and transport.
Calitz C; Steenekamp JH; Steyn JD; Gouws C; Viljoen JM; Hamman JH
Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):991-1003. PubMed ID: 24831257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
